04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
This month’s Friday Five covers recent cases addressing eligibility requirements to qualify for dis...
Read More >
On May 31, the Federal Trade Commission (“FTC”) posted the agenda for its final hearing in the “C...
Read More >
The Small Business Administration issued long-awaited rules governing lender and borrower obligation...
Read More >
Have you ever thought about what it would be like to work in a compliance program where you are also...
Read More >
The Mexican government announced a US$145 million (MX$300 billion) infrastructure investment plan to...
Read More >
In Part 1 of this series of posts, we discussed how business owners must think beyond the near term ...
Read More >